NurExone Biologic Inc.

C$0.50As of Sun 8 Nov 2026, 12:00 UTC
TSXV:NRXHealthcare
Country Canada
PE (Fwd) •••
TSR 4Y CAGR (4.10%)
Div yield —
ROE (450.96%)
Biotechnology
Beta (5Y) 0.34
PE TTM —
TSR TTM (28.57%)
Mkt cap C$48.20M
ROIC (264.92%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.593
18.70%
111.23%
Hold 4|11|6|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
19.06%
26.51%
23.36%
22.27%
Revenue$M
2.178
2.223
2.203
2.307
1.33%
5.07%
4.04%
8.36%
Peers (US$34.12M)
Cap (US$)
PE
34.16M
76.75x
Capital
TTM
5Y
10Y
Leveragex
1.067
7.249
5.120
EBIT/Intx
2.718
0.971
0.863
Own earn%
(98.92)
(4.88)
(3.22)
Sh yield%
36.70
9.26
10.72
Owners
Insiders/Inst%
11.80
75.20
Short interest%
5.31
SBC / revenue%
5.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
32–42
$1 testx
—
Incr. ROIC%
3